Trial intelligence / Profile preview

Remimazolam versus propofol anesthesia during EBUS-TBNA

ChiCTR2000040041Phase 4Completed

Sponsor
Fujian Medical University Union Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in bronchial carcinoma comparing Propofol group with Remimazolam group (2 arms). Primary endpoints: Blood pressure, Heart rate and 3 more. Started Nov 2020; status: completed.

02

Drugs

remimazolampropofol
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR2000040041.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call